Recent Finacing
Recent Raise
PAQ Therapeutics develops targeted protein degraders aimed at treating KRAS-driven cancers.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at PAQ Therapeutics.
